Confocal Microscopy: Identifying Chemotherapy-Induced Neuropathy Biomarkers

Archyde: Latest World News, Economy, Entertainment, Health, Technology & Sports Updates Revolutionizing Cancer Care: early Detection of Chemotherapy-Induced Peripheral Neuropathy Chemotherapy, a cornerstone of cancer treatment, frequently enough comes with debilitating side effects. Among the most prevalent is chemotherapy-Induced Peripheral Neuropathy (CIPN), a nerve-damaging condition affecting countless patients. But what if early detection, before symptoms … Read more

Confocal microscopy may help identify biomarkers for chemotherapy-induced neuropathy

A University of Arizona Comprehensive Cancer Center researcher received a $2.4 million National Cancer Institute grant to develop a noninvasive, confocal microscope to examine nerve endings of cancer patients with chemotherapy-induced peripheral neuropathy in the hopes of identifying potential biomarkers for the disease. Peripheral neuropathy is a common side effect of certain chemotherapy drugs. Chemotherapy-induced peripheral neuropathy, or CIPN, … Read more

Confocal-based high-content imaging in advancing core facilities

In this interview, NewsMedical speaks with Arvonn Tully and Esther Kieserman from Yokogawa Life Science about how confocal-based high-content imaging is advancing core facility research and improving data reliability. Could you introduce yourselves and share your background, particularly your work with confocal-based high-content imaging and analysis? Esther Kieserman (EK): I have worked in the microscopy … Read more

Aurox expands activity into North America

Aurox, the laser free confocal imaging company, is expanding its activities into North America. Established back in 2004, Aurox has been at the forefront of confocal microscopy since its inception. Its founders have been leaders in confocal imaging and advanced photonics since the 1980’s. For over 20 years its developments have been found inside the … Read more